These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3893781)
1. Mutagenicity and tumor initiating activity of methylated benzo[b]fluoranthenes. Amin S; Huie K; Hecht SS Carcinogenesis; 1985 Jul; 6(7):1023-5. PubMed ID: 3893781 [TBL] [Abstract][Full Text] [Related]
2. Mutagenicity and tumor initiating activity of methylated benzo[k] fluoranthenes. Amin S; Hussain N; Balanikas G; Huie K; Hecht SS Cancer Lett; 1985 Apr; 26(3):343-7. PubMed ID: 3995506 [TBL] [Abstract][Full Text] [Related]
3. Studies on the mutagenicity and tumor-initiating activity of methylated fluorenes. Lavoie EJ; Coleman DT; Geddie NG; Rice JE Chem Biol Interact; 1985 Jan; 52(3):301-9. PubMed ID: 3882256 [TBL] [Abstract][Full Text] [Related]
4. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives. Utesch D; Glatt H; Oesch F Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447 [TBL] [Abstract][Full Text] [Related]
5. Tumorigenic activity of non-alternant polynuclear aromatic hydrocarbons in newborn mice. Lavoie EJ; Braley J; Rice JE; Rivenson A Cancer Lett; 1987 Jan; 34(1):15-20. PubMed ID: 3802065 [TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of some methylated benzo[a]pyrene derivatives. Santella R; Kinoshita T; Jeffrey AM Mutat Res; 1982; 104(4-5):209-13. PubMed ID: 6287248 [TBL] [Abstract][Full Text] [Related]
7. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds. Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084 [TBL] [Abstract][Full Text] [Related]
8. Effect of fluorine substitution on benzo[j]fluoranthene genotoxicity. Weyand EH; He ZM; Ghodrati F; Wu Y; Marshall MV; LaVoie EJ Chem Biol Interact; 1992 Sep; 84(1):37-53. PubMed ID: 1394615 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene. Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665 [TBL] [Abstract][Full Text] [Related]
10. Relative tumor initiating activity of benzo[a]fluoranthene, benzo[b]fluoranthene, naphtho[1,2-b]fluoranthene and naphtho[2,1-a]fluoranthene on mouse skin. Weyand EH; Patel S; LaVoie EJ; Cho B; Harvey RG Cancer Lett; 1990 Jul; 52(3):229-33. PubMed ID: 2379145 [TBL] [Abstract][Full Text] [Related]
11. Tumour initiating activity of dihydrodiols of benzo[b]fluoranthene, benzo[j]fluoranthene, and benzo[k]fluoranthene. LaVoie EJ; Amin S; Hecht SS; Furuya K; Hoffmann D Carcinogenesis; 1982; 3(1):49-52. PubMed ID: 7067037 [TBL] [Abstract][Full Text] [Related]
12. Marked differences between mutagenicity in Salmonella and tumour-initiating activities of dibenzo[a,e]fluoranthene proximate metabolites; initiation inhibiting activity of norharman. Zajdela F; Perin-Roussel O; Saguem S Carcinogenesis; 1987 Mar; 8(3):461-4. PubMed ID: 3545527 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and tumor-initiating activities of dimethylchrysenes. Amin S; Balanikas G; Huie K; Hecht SS Chem Res Toxicol; 1988; 1(6):349-55. PubMed ID: 2979752 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the tumor-initiating activity of 4-, 5-, 6-, and 7-fluorobenzo[b]fluoranthene in mouse skin. LaVoie EJ; Cai ZW; Meegalla RL; Weyand EH Chem Biol Interact; 1993 Dec; 89(2-3):129-39. PubMed ID: 8269542 [TBL] [Abstract][Full Text] [Related]
15. Exceptional tumor-initiating activity of 4-fluorobenzo[j]-fluoranthene on mouse skin: comparison with benzo[j]-fluoranthene, 10-fluoro-benzo[j]fluoranthene, benzo[a]pyrene, dibenzo[a,l]pyrene and 7,12-dimethylbenz[a]anthracene. LaVoie EJ; He ZM; Meegalla RL; Weyand EH Cancer Lett; 1993 Jun; 70(1-2):7-14. PubMed ID: 8330304 [TBL] [Abstract][Full Text] [Related]
16. Tumor-initiating activity, mutagenicity, and metabolism of methylated anthracenes. La Voie EJ; Coleman DT; Rice JE; Geddie NG; Hoffmann D Carcinogenesis; 1985 Oct; 6(10):1483-8. PubMed ID: 3899400 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids. Huang MT; Wood AW; Newmark HL; Sayer JM; Yagi H; Jerina DM; Conney AH Carcinogenesis; 1983 Dec; 4(12):1631-7. PubMed ID: 6360409 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid. Wood AW; Huang MT; Chang RL; Newmark HL; Lehr RE; Yagi H; Sayer JM; Jerina DM; Conney AH Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5513-7. PubMed ID: 6752950 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the mutagenicity of compounds of known carcinogenicity, belonging to the benz[a]anthracene, chrysene, and cyclopenta[a]phenanthrene series, using Ames's test. Coombs MM; Dixon C; Kissonerghis AM Cancer Res; 1976 Dec; 36(12):4525-9. PubMed ID: 793712 [TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of 9-hydroxymethyl-10-methylanthracene and 1-hydroxymethylpyrene to electrophilic, mutagenic and tumorigenic sulfuric acid esters by rat hepatic sulfotransferase activity. Surh YJ; Blomquist JC; Liem A; Miller JA Carcinogenesis; 1990 Sep; 11(9):1451-60. PubMed ID: 2205404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]